CareONE Health · MemorEM Research Study · Now Screening
CareONE Healthin partnership with NeuroEM Therapeutics
Ask about screening
Research Study · Now Screening

A research study for Alzheimer's and related neurological conditions

Evaluating the investigational MemorEM wearable device from NeuroEM Therapeutics, in partnership with CareONE Health.

Begin the screening processView study cost
Home-based participationBRANY IRB–overseenInvestigational, not FDA-approvedListed on ClinicalTrials.gov
⚠ MemorEM is an investigational device. It has not been approved by the FDA, and participation in this study does not imply access to an approved treatment. Individual benefits are not guaranteed.
About the Study

What this study is evaluating

CareONE Health, in partnership with NeuroEM Therapeutics, is conducting a research study to evaluate the user experience of an investigational device called the MemorEM. The MemorEM is a wearable cap that delivers Transcranial Electromagnetic Treatment with Radio Frequencies (TEMT-RF). This study is designed to collect real-world feedback on how patients and caregivers use the device and their observations during daily use.

The Device

MemorEM Wearable Cap

Delivers Transcranial Electromagnetic Treatment with Radio Frequencies (TEMT-RF). Worn at home, twice daily, one hour per session.

This study is designed to collect real-world feedback on how patients and caregivers use the device and their observations during daily use.
— From the CareONE Health study overview
Key Facts

What participation involves

  • 01Participation involves wearing the cap twice daily for one hour per session.
  • 02The study is home-based and includes regular remote check-ins.
  • 03Participants will complete monthly cognitive surveys and medication reviews.
  • 04This device is investigational and not FDA-approved.
Who Can Join

Eligibility

May be eligible

  • Individuals diagnosed with Alzheimer's disease, Parkinson's, dementia, or a related neurological condition
  • Must have a caregiver to assist with use and study requirements

Also required

  • Must meet eligibility criteria determined by our clinical team
  • Must complete an informed consent process approved by the BRANY IRB

All participants must complete an informed consent process approved by the BRANY IRB before joining the study.

Study Cost

What is the cost?

For the first year, participants pay a one-time fee of:

MemorEM device$3,500
CareONE study support & clinical coordination$1,500
Total, first year$5,000

A 2.8% credit card fee ($140) applies if that payment method is used.

Financing is available for qualified applicants.
Why Participate

What this study offers

Access to a novel device

Access to a novel investigational device under study for Alzheimer's and related conditions.

Contribute to research

A chance to contribute to Alzheimer's research alongside other participants and caregivers.

Close clinical support

Close clinical support throughout your participation, including regular check-ins.

While individual benefits are not guaranteed, previous small-scale studies showed signs of improved cognitive performance in some participants.

FAQ

Frequently asked questions

What is MemorEM?＋
MemorEM is a wearable cap developed by NeuroEM Therapeutics that delivers Transcranial Electromagnetic Treatment with Radio Frequencies (TEMT-RF). It is investigational and has not been approved by the FDA.
Is MemorEM FDA-approved?＋
No. The MemorEM device has not been approved by the U.S. Food and Drug Administration. Participation in this study does not imply access to an approved treatment.
What does participation involve?＋
Participation involves wearing the cap twice daily for one hour per session. The study is home-based and includes regular remote check-ins, monthly cognitive surveys, and medication reviews.
Who is eligible to join?＋
Individuals diagnosed with Alzheimer's disease, Parkinson's, dementia, or a related neurological condition may be eligible. Participants must have a caregiver and meet eligibility criteria determined by the clinical team.
What does the study cost?＋
For the first year, participants pay a one-time fee of $5,000. A 2.8% credit card fee ($140) applies if that payment method is used. Financing is available for qualified applicants.
Are benefits guaranteed?＋
No. Individual benefits are not guaranteed.
Who oversees this study?＋
This study is overseen by BRANY IRB and complies with federal regulations for research involving human participants.
How do I get started?＋
Click HERE to apply and begin the screening process.

Interested in learning more?

Click on the link below to begin the learning process.

Click HERE to apply.